Elizabeth An Yu, MD
Critical Care (Intensivists) · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Yu’s office at (650) 691-6174 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A148759 · Current
Licensed to practise in California · since 2017 · expires 2026-10-31 · University of Massachusetts Medical School.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$127,795
Medicare paid this office $127,795 for 292 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 100 | $39,873 | $185 |
| Long return visit (40+ min) | 76 | $17,498 | $165 |
| New patient visit (60+ min) | 50 | $9,513 | $190 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 46 | $7,006 | $149 |
| Critical care, each additional 30 minutes | 40 | $5,150 | $92 |
See all 19 services
| Critical care, first 30-74 minutes | 100 | $39,873 | $185 |
| Long return visit (40+ min) | 76 | $17,498 | $165 |
| New patient visit (60+ min) | 50 | $9,513 | $190 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 46 | $7,006 | $149 |
| Critical care, each additional 30 minutes | 40 | $5,150 | $92 |
| Return visit (30+ min) | 35 | $4,965 | $115 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 45 | $3,893 | $83 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 28 | $3,750 | $129 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,736 | $156 |
| Short return visit (20+ min) | 38 | $3,719 | $83 |
| Review by radiologist of ct guidance for needle placement | 44 | $2,767 | $61 |
| Placement of radiation therapy markers into lung airways using an endoscope | 27 | $2,648 | $95 |
| Test to examine how well the lungs exchange gases | 33 | $2,160 | $58 |
| Test to determine lung volumes using sensors | 32 | $2,130 | $59 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 45 | $1,809 | $39 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 29 | $1,246 | $40 |
| Aspiration of initial secretion of lung airway using an endoscope | 19 | $992 | $52 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 31 | $866 | $27 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 13 | $694 | $29 |
Who their Medicare patients are
292 Original Medicare patients in 2024. Average age 77 · Under 65 4% · 85 and older 21% · Women 49% · Also on Medicaid 21% · Health risk score 2.11. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 2.58.
Conditions among them: High blood pressure 75% · Coronary heart disease 39% · Atrial fibrillation 38% · Chronic kidney disease 36% · COPD 35% · Diabetes 33% · Cancer 32% · Heart failure 31% · Depression 23% · Dementia 19% · Stroke 15%.
The office billed $1,287,294, Medicare allowed $163,831 and paid $127,795; for 1,114 services of 59 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 292 | 1,114 | 77 | 2.11 | $1,287,294 | $127,795 |
| 2023 | 269 | 1,084 | 77 | 1.89 | $1,252,732 | $127,647 |
| 2022 | 66 | 165 | 78 | 2.22 | $162,383 | $24,019 |
| 2021 | 58 | 85 | 69 | 3.53 | $19,647 | $3,262 |
| 2020 | 18 | 33 | 73 | 1.79 | $25,804 | $4,322 |
| 2017 | 43 | 134 | 74 | 2.63 | $35,125 | $10,005 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Critical care, first 30-74 minutes | 85 | $39,259 | $191 |
| Long return visit (40+ min) | 87 | $18,797 | $172 |
| New patient visit (60+ min) | 59 | $11,537 | $196 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 46 | $7,208 | $150 |
| Return visit (30+ min) | 36 | $5,316 | $118 |
| Critical care, each additional 30 minutes | 26 | $4,342 | $96 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 46 | $3,993 | $83 |
| Review by radiologist of ct guidance for needle placement | 50 | $3,344 | $64 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 22 | $3,272 | $142 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,879 | $160 |
| Placement of radiation therapy markers into lung airways using an endoscope | 24 | $2,532 | $101 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 51 | $2,501 | $48 |
| Short return visit (20+ min) | 20 | $1,780 | $85 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 34 | $1,659 | $30 |
| Test to examine how well the lungs exchange gases | 30 | $1,597 | $53 |
| Test to determine lung volumes using sensors | 30 | $1,546 | $52 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 33 | $1,118 | $34 |
| Aspiration of initial secretion of lung airway using an endoscope | 12 | $694 | $53 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 33 | $435 | $13 |
2022: 4 services
| Critical care, first 30-74 minutes | 16 | $6,710 | $192 |
| New patient visit (60+ min) | 21 | $4,358 | $208 |
| Long return visit (40+ min) | 14 | $2,568 | $171 |
| Return visit (30+ min) | 13 | $1,594 | $123 |
2021: 2 services
| Test to measure expiratory airflow and volume | 39 | $276 | $7 |
| Test to examine how well the lungs exchange gases | 19 | $145 | $8 |
2017: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,883 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,493 | $107 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,354 | $62 |
Medicaid work
$1,200 in 2024
Medicaid paid $1,200 for 24 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 24 | $1,200 |
| 2024 | 24 | 1 | 12 | $1,200 |
| 2021 | 26 | 1 | 14 | $192 |
See the largest Medicaid services in earlier years
2021
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 26 | $192 |
Drugs they prescribed that Part D paid
$309,391
Pharmacies billed $309,391 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 255) in 2024. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 0%.
82 generic and 173 brand-name prescriptions · $309,391 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ofev | 17 | $218,352 | $12,844 |
| Trelegy Ellipta | 47 | $36,108 | $768 |
| Breo Ellipta | 12 | $8,614 | $718 |
| Ventolin Hfa | 26 | $1,429 | $55 |
| Albuterol Sulfate Hfa | 31 | $900 | $29 |
Year by year
| 2024 | 255 | 45 | 0% (0) | 68% | $309,391 |
| 2023 | 140 | 39 | None | 70% | $51,657 |
| 2022 | 28 | 13 | 0% (0) | None | $2,788 |
| 2016 | 50 | 17 | 0% (0) | None | $685 |
| 2015 | 61 | 24 | None | None | $2,174 |
| 2014 | 117 | 44 | None | 26% | $6,068 |
| 2013 | 76 | 19 | None | None | $12,236 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Trelegy Ellipta | 20 | $17,630 | $881 |
| Symbicort | 26 | $11,128 | $428 |
| Spiriva Handihaler | 13 | $9,294 | $715 |
| Ventolin Hfa | 14 | $865 | $62 |
2014: 1 drug
| Amlodipine Besylate | 12 | $66 | $5 |
Money from drug and device companies
$4,225 in 2025
| 2025 | 4 | 9 | $3,000 | $4,225 |
| 2024 | 2 | 4 | $1,000 | $1,156 |
| 2023 | 1 | 3 | $1,000 | $1,262 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Intuitive Surgical | Da Vinci Surgical System | $4,135 | 5 payments
|
| GlaxoSmithKline | Nucala | $46 | 2 payments
|
| Philips North America | Vest Therapy Und | $28 | 1 payment
|
| Amgen | Tavneos | $17 | 1 payment
|
See all 9 published payments
| Intuitive Surgical | Meals · 2025-10-14 | Da Vinci Surgical System | $135 |
| Intuitive Surgical | Education · 2025-09-10 | Da Vinci Surgical System | $1,000 |
| Intuitive Surgical | Paid to speak or teach · 2025-09-05 | Da Vinci Surgical System | $1,000 |
| Intuitive Surgical | Paid to speak or teach · 2025-09-05 | Da Vinci Surgical System | $1,000 |
| Intuitive Surgical | Paid to speak or teach · 2025-09-05 | Da Vinci Surgical System | $1,000 |
| Amgen | Meals · 2025-06-27 | Tavneos | $17 |
| GlaxoSmithKline | Meals · 2025-05-12 | Nucala | $20 |
| GlaxoSmithKline | Meals · 2025-05-08 | Nucala | $26 |
| Philips North America | Meals · 2025-04-23 | Vest Therapy Und | $28 |
See earlier years (2024, 2023)
2024: $1,156
| Intuitive Surgical | Da Vinci Surgical System | $1,123 | 3 payments
|
| Amgen | Tezspire | $33 | 1 payment
|
2023: $1,262
| Intuitive Surgical | Da Vinci Sp | $1,262 | 3 payments
|
Professional record
- NPI
- 1841639416
- Licence
- CA 148759, MA 256716California A148759: Current · expires 2026-10-31
- Trained
- University of Massachusetts Medical School, 2013
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2013-06-17
- NPI last updated
- 2021-07-16
- NPI record certified
- 2021-07-16
This is when the NPI record was last certified, not a medical board exam.